Salomon Rayek, CEO at Sinbiotik, explains how the company managed to adapt its business model to the industry trends and showcases the added value of Sinbiotik when offering high quality, cost-effective and fully regulated APIs manufactured locally.
Could you please introduce yourself to our international audience as well as the key activities and operations of Sinbiotik?
"Our biggest accomplishment during the last five years has been the consolidation of our manufacturing site thanks to the investments that we have recently carried out. Indeed, this year we have just finished building up a new manufacturing facility."
Tags:
